Between 40% and 80% of the variation in human intelligence (IQ) is attributable to genetic factors. Except for many rare mutations resulting in severe cognitive dysfunction, attempts to identify these factors have not been successful. We report a genomewide linkage scan involving 634 sibling pairs designed to identify chromosomal regions that explain variation in IQ. Model-free multipoint linkage analysis revealed evidence of a significant quantitative-trait locus for performance IQ at 2q24.1-31.1 (LOD score 4.42), which overlaps the 2q21-33 region that has repeatedly shown linkage to autism. A second region revealed suggestive linkage for both full-scale and verbal IQs on 6p25.3-22.3 (LOD score 3.20 for full-scale IQ and 2.33 for verbal IQ), overlapping marginally with the 6p22.3-21.31 region implicated in reading disability and dyslexia.
but more-prevalent forms of impaired cognitive functioning, which are often associated with autism, schizophrenia, reading disorder, and attention deficit hyperactivity disorder (Goldman-Rakic 1999; Willcutt et al. 2001; Badcock et al. 2005) .
A major effort in identifying genetic variants that influence cognitive ability in the normal range was undertaken by Plomin and colleagues (Petrill et al. 1996; Chorney et al. 1998; Fisher et al. 1999a; Plomin et al. 2001 Plomin et al. , 2004 Butcher et al. 2005) . The only association that survived rigorous adjustment for multiple testing was a significant association of a functional polymorphism in the ALDH5A1 gene (MIM 271980) with cognitive ability (Plomin et al. 2004 ). This association was based on a selected sample (subjects with high IQs vs. subjects with normal IQs), and the effect size was rather small. Thus, in spite of the overwhelming evidence from twin studies of the existence of "genes for human intelligence," the actual identification of such genes through well-designed candidate-gene or whole-genome allelic association studies has not met with large success. It might be that these pre-HapMap studies did not achieve a high enough SNP density. Generally, association analyses may overlook closely spaced genes that act in concert to affect a trait. In contrast, linkage analysis is more sensitive to such concerted effects. For example, Yalcin et al. (2004) recently suggested such a mechanism for emotionality in mice, in which multiple closely linked genes on chromosome 1 may be needed to explain the solid linkage found in this region (Yalcin et al. 2004 ).
Here, we report the first genomewide linkage study for intelligence, using two unselected samples consisting of 725 individuals from 329 Australian families, which yield 475 sib pairs, and 225 individuals from 100 Dutch families, which yield 159 sib pairs. In these populations, the contribution of genetic factors to full-scale IQ (FSIQ) was shown to be 0.69 in the Australian sample (Luciano et al. 2004 ) and 0.86 in the Dutch sample . Heritabilities for verbal IQ (VIQ) and performance IQ (PIQ) were also high (table 1) .
The sample of Australian DZ twins and siblings was part of an ongoing study of cognition in adolescents (Wright et al. 2001; Luciano et al. 2004 ) and was genotyped as part of an earlier study that investigated melanoma risk factors (Zhu et al. 1999) . The study was approved by the Human Research Ethics Committee of the Queensland Institute of Medical Research Institute. Informed consent to jointly examine the cognitive and genotype data was obtained from participants or the parents/guardians of participants who were !18 years of age. The Multidimensional Aptitude Battery (MAB) (Jackson 1998 ) was used to assess IQ and consisted of three verbal subtests (information, vocabulary, and arithmetic) and two performance subtests (spatial ability and object assembly), which were administered by computer and were each timed at 7 min. Scaled scores for VIQ, PIQ, and FSIQ were examined. VIQ, PIQ, and FSIQ were normally distributed. IQ scores assessed with the MAB generally correlate highly with those assessed by the WAIS (Wechsler 1997): for VIQ, r p 0.94 r p for PIQ, and for FSIQ (Jackson 1998) . 0.79 r p 0.91 Genotyping of the Australian sample was performed at two facilities, the Australian Genome Research Facility, by use of the ABI PRISM Linkage Mapping Set v2.5, and the Center for Inherited Disease Research, by use of a marker set based on the Marshfield Genetics version 8 screening set.
Up to 761 autosomal microsatellite markers were typed at approximately equal intervals (average 4.8 cM) across the entire genome, with locations determined from the sex-averaged deCODE map (Kong et al. 2002) and interpolation of unmapped markers (Zhu et al. 2004) . Marker heterozygosity ranged from 52.6% to 91.9%. In the Australian sample, both parental genotypes were available for 260 families, one parental genotype for 67 families, and no parental genotypes for 34 families. Parents were typed for 228-784 markers (mean ‫ע‬ SD, 398 ‫ע‬ 101 markers). For twins and siblings, the number of typed markers ranged from 211 to 790, with an average of 601 ‫ע‬ 192 total markers.
The sample of Dutch DZ twins and siblings were part of an ongoing study of cognition in adults Wright et al. 2001) . Subjects were recruited from The Netherlands Twin Register to participate in the cognition study, and they gave written informed consent. The institutional review board of the Vrije Universiteit Medical Centre approved the DNA sampling and cognitive testing. The Dutch adaptation of the WAIS III-R (Wechsler 1997 ) was used to assess IQ and consisted of four verbal subtests (information, similarities, vocabulary, and arithmetic) and three performance subtests (picture completion, block design, and matrix reasoning). Scaled scores for VIQ, PIQ, and FSIQ were examined. VIQ, PIQ, and FSIQ were normally distributed. In 93 subjects, a genome scan with 369 autosomal markers (with 9.44-cM spacing) was done by the Mammalian Genotyping Service, with microsatellite screening set 10 with few alternative markers. In 132 subjects, a 419-marker genome scan (with 8.34-cM spacing) was performed by the Molecular Epidemiology Section, Leiden University Medical Centre (Heijmans et al., in press ). Parents were typed for 344-375 markers (mean 363 ‫ע‬ 6). For offspring, the number of typed markers ranged from 344 to 678, with an average of 389 ‫ע‬ 69 total markers.
Marker locations in the Australian and Dutch data sets were taken from an integrated genetic map with interpolated genetic map positions (see Web Resources section). The positions are in deCODE cM (Kong et al. 2002) , estimated via locally weighted linear regression (lo(w)ess) from the build 34.3 (and 35.1) physical map positions and from published deCODE and Marshfield genetic map positions. Mendelian errors were detected using PEDSTATS, and unlikely double recombinants were detected using MERLIN; both were removed using PEDWIPE (Abecasis et al. 2002) . Pedigree relationships in the entire sample were checked with the GRR program (Abecasis et al. 2001) .
A variance-components (VC) approach was used to evaluate linkage. The VC framework involves partitioning the variance of the trait of interest into components due to covariates, component(s) due to a major QTL, a polygenic component, and unique environmental or random variation. Estimation of the QTL effect requires the use of genetic data in the form of pairwise identity-bydescent (IBD) sharing between siblings. The multipoint probabilities of sharing 0, 1, or 2 alleles IBD were computed separately for each sample by use of a 1-cM grid with the Lander-Green algorithm implemented in MER-LIN (Abecasis et al. 2002) . These IBD probabilities were used to estimate linkage with the use of Mx software (Neale et al. 1997 ). For both data sets, age and sex were included as covariates in the analyses. All parameter estimates were initially allowed to differ between the two data sets. To test for heterogeneity in the variance associated with a putative QTL ( ), we ran a second scan in which we 2 j q restricted to be the same across both data sets while 2 j q allowing all other parameters, such as the polygenic effect, to be different. Heterogeneity of the QTL effect across the Dutch and Australian data sets could then be determined by the likelihood-ratio test, where the null model of no heterogeneity included a single QTL effect and the alternative model of heterogeneity included two separate QTL effects, for each genomic position. If no heterogeneity in is observed, the combined analysis 2 j q can be used to determine significance of the QTL effect on the basis of the pooled data set. Of all 3,543 genomic positions tested (by use of a 1-cM grid), only 1.2% for PIQ, 3.2% for VIQ, and 0.9% for FSIQ showed a x 2 value 13.84 (asymptotic ) at positions not lo-P p .05 cated under our peak regions.
Significance of genetic variation due to the QTL was evaluated by the likelihood-ratio test, which is a 50:50 mixture of a x 2 distribution with 1 df and a point mass at zero, comparing a model that included the variance associated with a QTL and a model that did not include this component. The LOD score can then be calculated by dividing the test statistic x 2 by 2ln10 (∼4.6). Linkage analyses were also performed using MERLIN, with option -vc for VC linkage analysis, and the results did not show notable differences from the results based on Mx presented here. However, the advantage of Mx is that possible heterogeneity in means, variance, effect of covariates, or polygenic heritability can be included in the statistical model.
To obtain empirical estimates of genomewide significance levels, 1,000 permutations of the data set were performed, with both the family structure and the IBD structure kept intact. These permutations allowed us to account for uneven marker spacing and informativeness and to calculate the probability of observing multiple peaks of a certain height (Churchill and Doerge 1994) . The permuted data sets were obtained so that each row in the observed data set represents one family and contains phenotypic data for each individual within that family as well as the precalculated (using MERLIN) IBD probabilities across the whole genome for all pairs within that family. This file is split into a phenotypic file (containing the IQ data as well as age, sex, and country identifier) and a genotypic file (containing the IBD probabilities). Families in the experiment are labeled with unique numbers 1 through n. The phenotypic data are then shuffled by taking a random permutation of the indices 1,…,n and matching the ith phenotypic trait value to the family with an index given by the ith element of permuted indices. This permuted vector of traits is matched with the original (unpermuted) genotypic information for all families. A total of 1,000 permuted data sets were generated under the assumption of no linkage; each permuted data set was then analyzed analogously to the observed data, and the highest peak for each chromosome was recorded. The empirical significance level of an observed LOD score was then estimated by counting the proportion of genome scans containing one or more peaks of that size. The cut-off for suggestive linkage was calculated as the score that was observed, on average, once per genome scan, thus representing the average maximum peak size expected once per genome scan by chance alone (Lander and Kruglyak 1995) . The thresholds for suggestive linkage for PIQ, VIQ, and FSIQ were 2.01, 1.70, and 1.86, respectively. The significant linkage threshold was defined as the LOD score occurring in 50 of the 1,000 permutations, corresponding to a probability of 0.05 in a genome scan (Lander and Kruglyak 1995) . The thresholds for significant linkage
Figure 1
Full autosomal genome scans for PIQ, VIQ, and FSIQ based on 634 sibling pairs. Horizontal solid lines denote genomewide empirical thresholds for significant linkage, defined as the LOD score that would be expected to occur by chance with a probability of 0.05 in a whole-genome scan. Horizontal dashed lines denote genomewide empirical thresholds for suggestive linkage, defined as the LOD score that would be expected to occur once by chance in a whole-genome scan (Lander and Kruglyak 1995). for PIQ, VIQ, and FSIQ were 3.39, 3.05, and 3.22, respectively.
Multipoint analyses revealed significant or suggestive evidence of linkage on two chromosomes (figs. 1 and 2). A single region, on chromosome 2q, revealed significant evidence of linkage to PIQ, at marker D2S2330 (LOD score 4.42). The evidence was reasonably supported by the Australian sample alone (LOD score 3.26) and was marginally supported (Lander and Kruglyak 1995) by the smaller Dutch sample (LOD score 1.53), which peaked at only a 5-cM difference. Heterogeneity tests confirmed that the QTL effects observed in the Australian and Dutch data sets in this region could indeed be combined into a single QTL effect. The borders (defined by a drop of 1 LOD score) of the positive peak at 2q are located at markers D2S142 and D2S2188, which are 16 cM apart (table 2). The shape of the scan for FSIQ score mirrored the findings for PIQ score on chromosome 2q, showing a peak LOD score of 2.23 within the same area.
On chromosome 6, we found suggestive evidence of linkage to FSIQ (LOD score 3.20) and, in the same region, to VIQ (LOD score of 2.33) at marker D6S942. The whole 1-LOD drop area spanned 42 cM (D6S942-D6S422).
Since the correlation between VIQ and PIQ is 0.53, which reflects that 28% of the variance in VIQ is shared with PIQ, we would expect that at least some of the QTLs that are important for VIQ are also important for PIQ. For the 2q24.1-2q31.1 region, linked to PIQ, we did not observe any evidence of linkage to VIQ. In the chromosome 6 region, linked to VIQ, the scan for PIQ showed a modest peak (LOD score 1.47) in the Australian data set in the same region as VIQ, implying that this region may be important for both VIQ and PIQ.
A few other regions showed LOD scores that were just below the thresholds for suggestive linkage (i.e., LOD score difference !0.3) ( fig. 1 ): on chromosome 4, VIQ showed a peak LOD score of 1.44 near marker D4S419; on chromosome 7, VIQ showed a peak LOD score of 1.56 near marker D7S3058; on chromosome 20, PIQ showed a peak LOD score of 1.84 near marker D20S851; and on chromosome 21, VIQ and FSIQ showed peak LOD scores of 1.56 and 1.59, respectively, at marker D21S1446. We further observed suggestive linkage for VIQ at 2qter in the Australian data set and at 2pter in the Dutch data set. Replication studies are needed to determine whether these LOD scores were due to chance or are derived from QTLs with small effects.
The 2q24.1-2q31.1 (D2S142-D2S2188) region that
Figure 2
Genomic regions with suggestive or significant linkage in the Dutch (blue), Australian (green), and combined (red) data sets. Vertical dotted lines represent the positions of the markers. Horizontal solid red lines denote genomewide empirical thresholds in the combined data set for significant linkage, defined as the LOD score that would be expected to occur by chance with a probability of 0.05 in a wholegenome scan. Horizontal dashed red lines denote genomewide empirical thresholds in the combined data set for suggestive linkage, defined as the LOD score that would be expected to occur once by chance in a whole-genome scan (Lander and Kruglyak 1995) . Information content, as a measure of entropy in the IBD distribution (Kruglyak et al. 1996) , in the Dutch (black) and Australian (gray) data sets is plotted in the top panels.
shows linkage to PIQ and FSIQ largely overlaps with the 2q21-33 region that has yielded suggestive linkage to autism in at least four independent genomic screens (Philippe et al. 1999; Buxbaum et al. 2001 ; International Molecular Genetic Study of Autism Consortium [IMGSAC] 2001; Shao et al. 2002) . The IMGSAC (2001) reported their highest LOD score (3.74) with language delay in autism-affected families at marker D2S2188, which lies 6 cM from the peak LOD score on 2q, whereas Buxbaum et al. (2001) reported their highest LOD score for phrase speech at marker D2S335, which lies 3 cM away from the peak LOD score found in our study. Recently, Raskind et al. (2005) conducted a genomewide scan for dyslexia and reported evidence of a QTL for speed of phonological decoding efficiency near marker D2S1399 at 2q. This marker lies 13 cM away from our peak marker at 2q with PIQ and lies next to the 1-LOD drop border.
Several positional candidate genes within the 2q24.1-2q31.1 linkage region have been tested for an association to autism, including GAD1 (MIM 605363),
, and SCN3A (MIM 182391) (Bacchelli et al. 2003; Weiss et al. 2003; Rabionet et al. 2004; Ramoz et al. 2004) . Most promising as a site with possible relevance to IQ is the significant association between the relative risk to autism and two common SNPs in the mitochondrial aspartate/glutamate carrier SLC25A12 gene (Ramoz et al. 2004) .
The linkage region on chromosome 6 (6p25.3-6p22.3 [D2S942-D2S422]) overlaps marginally with the region 6p22.3-6p21.3 implicated in reading disability and dyslexia (Cardon et al. 1994; Fisher et al. 1999b; Gayán et al. 1999; Grigorenko et al. 2000; Kaplan et al. 2002; Willcutt et al. 2002; Deffenbacher et al. 2004) . Although recently at least five candidate genes were identified that are likely to contribute to linkage with reading disability, those genes lie just outside the region defined by a drop of 1 LOD score on 6p for VIQ and FSIQ scores (Deffenbacher et al. 2004) . The ALDH5A1 gene (6p22-6p23), implicated in both cognitive ability (Plomin et al. 2004 ) and reading disability (Deffenbacher et al. 2004 ), lies at the border of our 6p region. [MIM 603650 ] at 2q31). These disorders are accompanied by rather severe cognitive impairment, but milder variants in these same genes could influence variation in the normal range of cognitive abilities. Recently, evidence was found for linkage at 6p24 to a neurocognitivedeficit subtype of schizophrenia, in which the maximum LOD score occurred at marker D6S309, which is within the region that shows linkage to VIQ and FSIQ (Hallmayer et al., in press ). Currently, dysbindin-1 (DTNBP1) at 6p22.3 is the best-supported susceptibility gene for schizophrenia (Talbot et al. 2004) . Recent identification of a relationship between dysbindin-1 and hippocampal glutamate neurotransmission, a core concept of leading neurobiological theories of memory and learning, suggests further potential as an IQ gene (Talbot et al. 2004) . A second positional candidate gene thought to be involved in memory processes is NRN1 (MIM 607409) at 6p25.1, which plays a role in neuritogenesis in mature brains. Naeve et al. (1997) showed that expression of neuritin, the product of NRN1, is induced by neural activity and by the activity-regulated brain-derived neurotrophic factor and neurotrophin-3. Neuritin is expressed in hippocampal and cortical neurons and is suspected to regulate neuronal plasticity during development and in the adult brain.
Given the gradual increase in heritability of IQ from childhood to late adolescence, those genes in our regions that influence brain development may be promising as candidate genes for IQ. For example, TBR-1 (MIM 604616), a neuron-specific T-box transcription factor, plays a critical role in brain development and is specifically expressed in the cortex. It is thought to be a common genetic determinant for the differentiation of earlyborn glutamatergic neocortical neurons and may provide insights into the functions of these neurons as regulators of cortical development (Hevner et al. 2001 (Hevner et al. , 2002 . More specifically, Hevner et al. (2002) showed, using Tbr1 mutant mice, that Tbr1 is critical in the appropriate establishment of precise reciprocal projections between cortical areas and corresponding thalamic nuclei.
In summary, a genome scan for intelligence has revealed two regions with putative evidence of linkage: 2q24.1-2q31.1 and 6p25.3-6p22.3. To identify these regions, we analyzed variation in cognition in healthy subjects. These areas were previously implicated in disorders that are accompanied by cognitive impairment, which supports the idea that trait variation within the normal range might be used to detect genes for (mental) disorders, such as autism, schizophrenia, or reading disability.
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